Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure

Moonki Hong, Junho Choi, Seoyoung Lee, Yun Beom Sang, Min Hee Hong, Ja Hyun Yeo, Joo-Hang Kim, Shinkyo Yoon, Chang Gon Kim, Hye Ryun Kim

Therapeutic Advances in Medical Oncology

Published online on June 27, 2026

Abstract

Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Determining an optimal treatment strategy after tyrosine kinase inhibitor (TKI) failure remains challenging in oncogene-driven non-small cell lung cancer (NSCLC).Objectives:We aimed to evaluate and compare the efficacy and safety of ...